BridgeMD
New treatment option for Lung Neoplasm Malignant
Official title Benefit of Spectral Information in Patients Suspected for Lung Cancer
ClinicalTrials.gov ID: NCT06440616
What this study is testing
- What it's testing
- Purpose The aim of the study is to investigate the utilization of photon counting CT (PCCT) and the spectral information provided to determine the impact of spectral information on follow-up examinations. As secondary aims we will compare conventional CT, CT + 18Flouro-deoxy-glucose (18F-FDG) positron emission tomography (PET) and PCCT + 18F-FDG PET for the tumor-node-metastasis (TNM) staging of lung cancer patients.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Patients suspected of lung cancer refered to Copenhagen University Hospital as per the guidelines from the danish national health authorities from...
- Informed consent
You likely can't join if
- Patients who cannot tolerate intravenous iodinated contrast
- Already verified lung cancer from another institution
- Comorbidities that exclude the patient from receiving treatment
- Lack of reference standard in the form of either histology or follow-up
- Known extrapulmonary malignancy
- Technical limitations within the scans/reconstructions
See the full eligibility criteria
- Patients suspected of lung cancer refered to Copenhagen University Hospital as per the guidelines from the danish national health authorities from either the general practitioner or from the department of pulmonology.
- Informed consent
- Patients who cannot tolerate intravenous iodinated contrast
- Already verified lung cancer from another institution
- Comorbidities that exclude the patient from receiving treatment
- Lack of reference standard in the form of either histology or follow-up
- Known extrapulmonary malignancy
- Technical limitations within the scans/reconstructions
- other Pr. the 29th of September included 433 participants.
The study team makes the final eligibility decision.
Where it's taking place
- Herlev, Capital Region, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Herlev, Capital Region, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.